Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eloxx Pharmaceuticals Inc (ELOX)  
$0.81 0.02 (2.65%) as of 4:30 Fri 4/26


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 2,170,000
Market Cap: 1.75(M)
Last Volume: 881,740 Avg Vol: 301,084
52 Week Range: $0.62 - $10.9
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing an oral small molecule ribosome modulating agents and eukaryotic ribosome selective glycosides (ERSGs) for the treatment of rare and ultra-rare premature stop codon diseases and ribosomal mutations. Co.'s TURBO-ZM™ platform is designed to enable synthesis of macrolides that can be supported to modulate the human, bacterial or viral ribosomes to treat rare diseases. ELX-02, an ERSG, is a small molecule drug candidate designed as an analogue to gentamicin and geneticin to restore production of functional proteins, and is in clinical development for the treatment of cystic fibrosis patients with nonsense mutations.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 264
  Page 5 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Forbes Christopher Director   –       •       •   2012-11-26 4 B $0.16 $400 D/D 2,500 12,757,318 3.84     -
   Rector David Director   –       •      –    2012-11-21 4 B $0.16 $5,890 D/D 38,000 352,785 2.39     -
   Waksal Harlan Director   –       •      –    2012-08-08 4 OE $0.26 $223,214 D/D 858,517 2,805,750     -
   Forbes Christopher Director   –       •       •   2012-08-08 4 OE $0.26 $1,116,072 D/D 4,292,583 12,754,818     -
   Browne Leslie J President and CEO   •       –      –    2012-03-29 4 B $0.26 $2,600 D/D 10,000 19,000 2.66     -
   Klaver Paul Edward 10% Owner   –       –       •   2012-03-22 4 GA $0.00 $0 I/I 3,000,000 10,146,527     -
   Klaver Paul Edward 10% Owner   –       –       •   2012-03-22 4 GD $0.00 $0 D/D 3,000,000 7,146,527     -
   Klaver Paul Edward 10% Owner   –       –       •   2012-03-15 4 GA $0.00 $0 I/I 2,000,000 10,146,527     -
   Klaver Paul Edward 10% Owner   –       –       •   2012-03-15 4 GD $0.00 $0 D/D 2,000,000 8,146,527     -
   Klaver Paul Edward 10% Owner   –       –       •   2012-03-12 3 IO $0.00 $0 I/I 0 206,300     -
   Klaver Paul Edward 10% Owner   –       –       •   2012-03-12 3 IO $0.00 $0 D/D 0 10,146,527     -
   Waksal Harlan Director   –       •      –    2012-01-06 4 B $0.26 $250,000 D/D 961,538 1,902,590 2.39     -
   Forbes Christopher Director   –       •       •   2012-01-06 4 B $0.26 $50,000 D/D 192,308 8,239,021 3.92     -
   Rector David Director   –       •      –    2011-12-07 4 B $0.24 $10,402 D/D 44,039 314,785 2.39     -
   Rector David Director   –       •      –    2011-06-13 4 B $0.27 $5,400 D/D 20,000 270,746 2.39     -
   Forbes Christopher Director   –       •       •   2011-03-22 4 B $0.28 $4,191 D/D 15,000 7,452,289 3.84     -
   Browne Leslie J President and CEO   •       •      –    2011-03-21 4 B $0.27 $805 D/D 3,000 9,000 2.73     -
   Browne Leslie J President and CEO   •       –      –    2011-02-24 4 B $0.29 $865 D/D 3,000 6,000 2.66     -
   Browne Leslie J President and CEO   •       –      –    2011-02-23 4 B $0.29 $857 D/D 3,000 3,000 2.66     -
   Isabelle Warren John Director   –       •      –    2010-05-25 4 OE $0.83 $64,607 D/D 77,840 101,764     -
   Isabelle Warren John Director   –       •      –    2010-05-25 4 A $0.37 $2,038 D/D 4,957 23,924     -
   Quick Thomas C Director   –       •      –    2010-05-25 4 OE $0.83 $261,236 D/D 314,742 814,907     -
   Quick Thomas C Director   –       •      –    2010-05-25 4 A $0.37 $8,242 D/D 20,045 500,165     -
   Van Hulst Jack Director   –       •      –    2010-05-25 4 OE $0.83 $25,281 D/D 30,459 40,068     -
   Van Hulst Jack Director   –       •      –    2010-05-25 4 A $0.37 $801 D/D 1,946 9,609     -
  264 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us